Skip to main content
. Author manuscript; available in PMC: 2017 May 9.
Published in final edited form as: J Allergy Clin Immunol Pract. 2016 Oct 17;5(3):816–818. doi: 10.1016/j.jaip.2016.08.012

Figure 1.

Figure 1

(A) Incidence of initial immediate hypersensitivity reactions among BRCA positive and negative patients. (B) Severity of initial hypersensitivity reactions to carboplatin (1: mild, 2: moderate and 3: severe) (9) among BRCA positive and negative patients.